Dental Journal of Advance Studies

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  12 (2024)
Volume  11 (2023)
Volume  10 (2022)
Volume  9 (2021)
Volume  8 (2020)
Volume  7 (2019)
Volume  6 (2018)
Volume  5 (2017)
Volume  4 (2016)
Volume  3 (2015)
Volume  2 (2014)
Volume  1 (2013)
Related articles

VOLUME 12 , ISSUE 1 ( January-April, 2024 ) > List of Articles

REVIEW ARTICLE

Orofacial Manifestations in COVID-19 Patients, Health Challenges and Dental Practice Recommendations during COVID-19 Pandemic: A Clinical Update

Shaveta Sood, Monia Sharma, Shalini Gugnani, Sonia B Bhardwaj

Keywords : Coronavirus disease-2019 pandemic, Oral manifestation, Severe acute respiratory syndrome coronavirus-2

Citation Information : Sood S, Sharma M, Gugnani S, Bhardwaj SB. Orofacial Manifestations in COVID-19 Patients, Health Challenges and Dental Practice Recommendations during COVID-19 Pandemic: A Clinical Update. 2024; 12 (1):44-48.

DOI: 10.5005/djas-11014-0042

License: CC BY-NC-ND 4.0

Published Online: 30-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

The coronavirus disease-2019 (COVID-19) pandemic has posed a challenge to healthcare system globally; dentistry being no exception. As the duration of a pandemic is increasing and new strains of the virus are being detected in various parts of the world, the dentist should be familiar with the list of oral manifestations and implications of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This will not only play an important role in diagnosing carriers but also equip the dental fraternity to deal with a surge of otherwise not-so-common oral diseases. Viruses are not new to the oral cavity, but here oral manifestations have importance in the detection of asymptomatic carriers of SARS-CoV-2. This article aims to compile available literature relevant to the oral health perspective in the era of COVID-19.

HTML PDF Share
  1. World Health Organization. Enhancing response to Omicron SARS-CoV-2 variant; Available from: https://www.who.int/news/items/28-11-2021-update-on-omicron.
  2. Xiang Z, Koo H, Chen Q, et al. Potential implications of SARS-CoV-2 oral infection in the host microbiota. J Oral Microbiol 2020;13(1):1853451. DOI: 10.1080/20002297.2020.1853451.
  3. Chakraborty T, Jamal RF, Battineni G, et al. A review of prolonged post-COVID-19 symptoms and their implications on dental management. Int J Environ Res Public Health 2021;18(10):5131. DOI: 10.3390/ijerph18105131.
  4. Rabi FA, Al Zoubi MS, Kasasbeh GA, et al. SARS-CoV-2 and coronavirus disease 2019: What we know so far. Pathogens 2020;9(3):231. DOI: 10.3390/pathogens9030231.
  5. Parasher A. COVID-19: Current understanding of its pathophysiology, clinical presentation and treatment. Postgrad Med J 2021;97(1147): 312–320. DOI: 10.1136/postgradmedj-2020-138577.
  6. Dos Santos JA, Normando AG, da Silva RL, et al. Oral mucosal lesions in a COVID-19 patient: New signs or secondary manifestations? Int J Infect Dis 2020;97:326–328. DOI: 10.1016/j.ijid.2020.06.012.
  7. Brandao TB, Gueiros LA, Melo TS, et al. Oral lesions in patients with SARS-CoV-2 infection: Could the oral cavity be a target organ? Oral Surg Oral Med OralPathol Oral Radiol 2021;131(2):e45–e51. DOI: 10.1016/j.oooo.2020.07.014.
  8. Katz J, Yue S, Xue W. Herpes simplex and herpes zoster viruses in COVID-19 patients. Ir J Med Sci 2022;191(3):1093–1097. DOI: 10.1007/s11845-021-02714-z.
  9. Vaira LA, Deiana G, Fois AG, et al. Objective evaluation of anosmia and ageusiain COVID-19 patients: Single-center experience on 72 cases. Head Neck 2020;42(6):1252–1258. DOI: 10.1002/hed. 26204.
  10. Printza A, Katotomichelakis M, Valsamidis K, et al. Smell and taste loss recovery time in COVID-19 patients and disease severity. J Clin Med 2021;10(5):966. DOI: 10.3390/jcm10050966.
  11. Fatehi Y, Hoseini EG, Atoof F, et al. Xerostomia in patients with COVID-19: A case series. Future Virol 2021;16(3):315–319. DOI: 10.2217/fvl-2020-0334.
  12. Bagley AF, Ye R, Garden AS, et al. Xerostomia–related quality of life for patients with oropharyngeal carcinoma treated with proton therapy. Radiother Oncol 2020;142:133–139. DOI: 10.1016/j.radonc.2019. 07.012.
  13. Riad A, Gad A, Hockova B, et al. Oral candidiasis in non-severe COVID-19 patients: Call for antibiotic stewardship. Oral Surg 2020;15(3):465–466. DOI: 10.1111/ors.12561.
  14. Katz J. Prevalance of candidiasis and oral candidiasisin COVID-19 patients: A cross-sectional pilot study from the patient's registry in a large health center. Quitessence Int 2021;52(8):714–718. DOI: 10.3290/j.qi.b1491959.
  15. CorchueloJ, Ulloa FC. Oral manifestation in a patient with a history of asymptomatic COVID-19: Case report. Int J Infect dis 2020;100: 154–157. DOI: 10.1016/j.ijid.2020.08.071.
  16. Singh AK, Singh R, Joshi SR, et al. Mucormycosis in COVID-19: A systematic review of cases reported worldwide and in India. Diabetes Metab Syndr 2021;15(4):102146. DOI: 10.1016/j.dsx.2021.05.019.
  17. Cornely OA, Alastruey-Izquierdo A, Arenz D, et al. Global guideline for the diagnosis and management of mucormycosis: An initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium. Lancet Infect Dis 2019;19(12):e405–e421. DOI: 10.1016/S1473-3099(19)30312-3.
  18. Alekseyev K, Didenko L, Chaudhry B. Rhinocerebral mucormycosis and COVID-19 pneumonia. J Med Cases 2021;12(3):85–89. DOI: 10.14740/jmc3637.
  19. Janjua OS, Shaikh MS, Fareed MA, et al. Dental and oral manifestations of COVID-19 related mucormycosis: Diagnosis, management strategies and outcomes. J Fungi (Basel) 2021;8(1):44. DOI: 10.3390/jof8010044.
  20. Bardan Z, Gaudin A, Struillou X, et al. Periodontal pocket: A potential reservoir for SARS-CoV-2? Med Hypotheses 2020;143:109907. DOI: 10.1016/j.mehy.2020.109907.
  21. Wang K, Chen W, Zhang Z, et al. SARS-CoV-2 invades host cells via a novel route: CD147-spike protein. Sig Transduct Target Ther 2020;5(1):283. DOI: 10.1038/s41392-020-00426-x.
  22. Jafer MA, Hazazi MA, Mashi MH, et al. COVID-19 and Periodontitis: A reality to live with. J Contemp Dent Pract 2020;21:1398–1403. PMID: 33893266.
  23. Alharbi A, AlharbiS, Alqaidi S. Guidelines for dental care provision during the COVID-19 pandemic. Saudi Dent J 2020;32(4):181–186. DOI: 10.1016/j.sdentj.2020.04.001.
  24. Guo H, Zhou Y, LiuX, et al. The impact of the COVID-19 epidemic on the utilization of emergency dental services. J Dent Sci 2020;15(4): 564–567. DOI: 10.1016/j.jds.2020.02.002.
  25. Parvaie P, Osmani F. Dentistry during COVID-19: Patients’ knowledge and satisfaction toward health protocols COVID-19 during dental treatment. Eur J Med Res 2022;27:3. DOI: 10.1186/s40001-021- 00629-0.
  26. Ministry of Health and Family Welfare (MOHFW), India. Guidelines for dental professionals in COVID-19 pandemic situation. Available from: https://www.mohfw.gov.in/pdf/NationalGuidelinesforSafe DentalPracticeDuringCovid19pandemic.pdf.
  27. Chopra A, Sivaraman K, Radhakrishnan R, et al. Can povidone iodine gargle/mouth rinse inactivate SARS-CoV-2 and decrease the risk of nosocomial and community transmission during the COVID-19 pandemic? An evidence–based update. Jpn Dent Sci Rev 2021;57: 39–45. DOI: 10.1016/j.jdsr.2021.03.001.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.